Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 8/2007

01.12.2007 | ORIGINAL CONTRIBUTION

Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder

verfasst von: D. Purper-Ouakil, MD, PhD, S. Cortese, MD, M. Wohl, MD, M. Asch, MD, E. Acquaviva, MD, B. Falissard, G. Michel, PhD, P. Gorwood, MD, PhD, M. C. Mouren, MD

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Background Early recognition of attention-deficit/hyperactivity disorder (ADHD) may improve the educational and psychosocial outcome of most affected children. To date, factors associated with diagnostic delay of ADHD have not specifically been addressed. Aims of this study were to evaluate the mean diagnostic delay (time between first consultation and definite diagnosis) in a clinical sample of French children with ADHD referred to an outpatient university clinic, and to determine associated factors. Method A total of 129 consecutively referred ADHD patients aged 6–16 years. A detailed history of the children was obtained from their parents. The Kiddie-SADS-PL, the ADHD-Rating Scale, and the Clinical Global Impression Scale were used for clinical assessment. Results Mean diagnostic delay was 32.89 months. A previous suspicion of ADHD by any health care professional, therapist or teacher was significantly associated with a reduced diagnostic delay. Co-morbidity with anxiety/depressive disorders and previous contact with a mental health professional were associated with a significant delay in diagnosis. Conclusion Delay in diagnosis of ADHD in France is among the longest reported. Children with co-morbid anxiety or depressive disorders are particularly at risk of having a significant delay in the diagnosis. Health professionals, therapists and teachers may play a relevant role to accelerate the diagnostic procedure.
Literatur
1.
Zurück zum Zitat American Academy of Pediatrics (2000) Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158–1170CrossRef American Academy of Pediatrics (2000) Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158–1170CrossRef
2.
Zurück zum Zitat Biederman J (2005) Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatr 57:1215–1220CrossRef Biederman J (2005) Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatr 57:1215–1220CrossRef
3.
Zurück zum Zitat Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1798PubMed Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1798PubMed
4.
Zurück zum Zitat Biederman J, Kwon A, Aleardi M, Chouinard VA, Marino T, Cole H, Mick E, Faraone SV (2005) Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry 162:1083–1089PubMedCrossRef Biederman J, Kwon A, Aleardi M, Chouinard VA, Marino T, Cole H, Mick E, Faraone SV (2005) Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry 162:1083–1089PubMedCrossRef
5.
Zurück zum Zitat Buitelaar JK (2002) Epidemiological aspects: what have we learned over the last decade? In: Sanberg S (ed) Hyperactivity and attention disorder of childhood. Cambridge University Press ed., Cambridge Buitelaar JK (2002) Epidemiological aspects: what have we learned over the last decade? In: Sanberg S (ed) Hyperactivity and attention disorder of childhood. Cambridge University Press ed., Cambridge
6.
Zurück zum Zitat Buitelaar JK, Rothenberger A (2004) Foreword—ADHD in the scientific and political context. Eur Child Adolesc Psychiatry 13(Suppl 1):I1–I6PubMed Buitelaar JK, Rothenberger A (2004) Foreword—ADHD in the scientific and political context. Eur Child Adolesc Psychiatry 13(Suppl 1):I1–I6PubMed
7.
Zurück zum Zitat Cantwell DP (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:978–987PubMedCrossRef Cantwell DP (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:978–987PubMedCrossRef
8.
Zurück zum Zitat DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD Rating Scale-IV: checklists, norms, and clinical interpretation. Guilford Press, New York, NY DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD Rating Scale-IV: checklists, norms, and clinical interpretation. Guilford Press, New York, NY
9.
Zurück zum Zitat Faraone SV (2005) The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry 14:1–10PubMedCrossRef Faraone SV (2005) The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry 14:1–10PubMedCrossRef
11.
Zurück zum Zitat Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ Payne JD (1999) Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 38:797–804PubMedCrossRef Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ Payne JD (1999) Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 38:797–804PubMedCrossRef
12.
Zurück zum Zitat Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988PubMedCrossRef Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988PubMedCrossRef
13.
Zurück zum Zitat Klasen H, Goodman R (2000) Parents and GPs at cross-purposes over hyperactivity: a qualitative study of possible barriers to treatment. Br J Gen Practitioner 50:199–202 Klasen H, Goodman R (2000) Parents and GPs at cross-purposes over hyperactivity: a qualitative study of possible barriers to treatment. Br J Gen Practitioner 50:199–202
14.
Zurück zum Zitat LeFever GB, Dawson KV, Morrow AL (1999) The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health 89:1359–1364PubMedCrossRef LeFever GB, Dawson KV, Morrow AL (1999) The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health 89:1359–1364PubMedCrossRef
15.
Zurück zum Zitat Marcelli D (1999) Enfance et psychopathologie. Masson, Paris Marcelli D (1999) Enfance et psychopathologie. Masson, Paris
16.
Zurück zum Zitat Mouren-Siméoni MC, Cook S, Flament M, Nedey-Saiag MC, Nollet-Clémençon C, Paillère-Martinot ML, Purper-Ouakil D,Vila G Kiddie-SADS-version vie entière (K-SADS-P/L) (2002) Edition revisée et modifiée. Editions INSERM Mouren-Siméoni MC, Cook S, Flament M, Nedey-Saiag MC, Nollet-Clémençon C, Paillère-Martinot ML, Purper-Ouakil D,Vila G Kiddie-SADS-version vie entière (K-SADS-P/L) (2002) Edition revisée et modifiée. Editions INSERM
17.
Zurück zum Zitat Ralston SJ, Lorenzo MJ (2004) ADORE—Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adolesc Psychiatry 13(Suppl 1):I36–I42PubMed Ralston SJ, Lorenzo MJ (2004) ADORE—Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adolesc Psychiatry 13(Suppl 1):I36–I42PubMed
18.
Zurück zum Zitat Rappley MD (2005) Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med 352:165–173PubMedCrossRef Rappley MD (2005) Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med 352:165–173PubMedCrossRef
19.
Zurück zum Zitat Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N (1990) A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416–425PubMedCrossRef Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N (1990) A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416–425PubMedCrossRef
20.
Zurück zum Zitat Steinhausen HC, Metzke CW, Meier M, Kannenberg R (1998) Prevalence of child and adolescent psychiatric disorders: the Zurich Epidemiological Study. Acta Psychiatrica Scandinavica 98:262–271PubMedCrossRef Steinhausen HC, Metzke CW, Meier M, Kannenberg R (1998) Prevalence of child and adolescent psychiatric disorders: the Zurich Epidemiological Study. Acta Psychiatrica Scandinavica 98:262–271PubMedCrossRef
21.
Zurück zum Zitat Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429–433PubMedCrossRef Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429–433PubMedCrossRef
22.
Zurück zum Zitat Taylor E, Sandberg S, Thorley G, Giles S (1991) The epidemiology of childhood hyperactivity. (Maudsley Monographs ed) (vols 33) London Taylor E, Sandberg S, Thorley G, Giles S (1991) The epidemiology of childhood hyperactivity. (Maudsley Monographs ed) (vols 33) London
23.
Zurück zum Zitat Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7–30PubMed Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7–30PubMed
24.
Zurück zum Zitat Vila G, Zipper E, Dabbas M, Bertrand C, Robert JJ, Ricour C, Mouren Siméoni MC (2004) Mental disorders in obese children and adolescents. Psychosom Med 66:387–394PubMedCrossRef Vila G, Zipper E, Dabbas M, Bertrand C, Robert JJ, Ricour C, Mouren Siméoni MC (2004) Mental disorders in obese children and adolescents. Psychosom Med 66:387–394PubMedCrossRef
25.
Zurück zum Zitat Wilens TE (1998) AOD use and attention deficit/hyperactivity disorder. Alcohol Health Res World 22:127–130PubMed Wilens TE (1998) AOD use and attention deficit/hyperactivity disorder. Alcohol Health Res World 22:127–130PubMed
26.
Zurück zum Zitat Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996) Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. Eur Child Adolesc Psychiatry 35:319–324CrossRef Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996) Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. Eur Child Adolesc Psychiatry 35:319–324CrossRef
28.
Zurück zum Zitat Zhang S, Faries DE, Volwes M, Michelson D (2005) ADHD rating scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 14:186–201PubMedCrossRef Zhang S, Faries DE, Volwes M, Michelson D (2005) ADHD rating scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 14:186–201PubMedCrossRef
Metadaten
Titel
Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder
verfasst von
D. Purper-Ouakil, MD, PhD
S. Cortese, MD
M. Wohl, MD
M. Asch, MD
E. Acquaviva, MD
B. Falissard
G. Michel, PhD
P. Gorwood, MD, PhD
M. C. Mouren, MD
Publikationsdatum
01.12.2007
Verlag
D. Steinkopff-Verlag
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 8/2007
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-007-0627-y

Weitere Artikel der Ausgabe 8/2007

European Child & Adolescent Psychiatry 8/2007 Zur Ausgabe

Erratum

Erratum

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.